Concord Medical Services Holdings Limited CCM

Full chart Compare

Set alert

3.85 USD +0.26 (+7.24%)

At closeNov 3, 2026, 4:00 PM EST

3.84 -0.01 -0.26%

After hours · Nov 3, 4:00 PM ET

3.39 Day range 4.01

2.79 52-week range 6.80

YTD: -0.26%
1 year: -30.00%

Market cap: 16.72M
Revenue (ttm): 471.70M
Profit margin: -80.33%
EPS (ttm): -2.96
Shares out: 2.82M
Forward P/E: -30.00
YTD return: -0.26%
1-year return: -30.00%

Volume: 61.70K
Avg volume: 44.90K
Open: 3.39
Previous close: 3.59
Day's range: 3.39 – 4.01
52-week range: 2.79 – 6.80
Beta: -0.27
Earnings date: Apr 29, 2019

1D 5D 1M 3M 6M YTD 1Y 2Y 5Y MAX

Full chart

2Y -4.11 (-52.69%)

Enterprise value: 7.88B
PEG ratio: 0.00
Price / sales: 0.04
Price / book: 0.00
Dividend yield: 0.00%
Payout ratio: 0.00%
Revenue growth: -23.10%
Free cash flow: 0
Total cash: 326.90M
Total debt: 3.56B
Return on equity: -32.40%
Short % of float: 0.00%
50-day average: 5.90
200-day average: 6.53

Apr 29, 2019

Expected Apr 29, 2019. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

CCM Revenue — annual 460.51M

CCM Net income — annual -92.81M

CCM EPS — annual -21.30

CCM recent earnings
Report date	Quarter ending	EPS estimate	EPS reported	Surprise	Surprise %
Apr 29, 2019	Dec 1, 2018	0.01	—	—	—
May 7, 2018	Dec 1, 2017	-0.06	—	—	—

CCM analyst upgrades and downgrades
Date	Firm	Action	From	To
Nov 23, 2012	Morgan Stanley	main	—	Overweight
Jul 6, 2012	Morgan Stanley	main	—	Overweight
Mar 22, 2012	JP Morgan	main	—	Overweight

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

Sector: Healthcare
Industry: Medical Care Facilities
Country: China
Website: concordmedical.com